Recently, Raveethiran et al. suggested that the addition of a diagnostic 68Ga-PSMA PET/CT to mpMRI can improve the detection of significant prostate cancer and improve the ability to identify men suitable for active surveillance [13]. This evidence concerns the gene FOLH1 and Familial prostate cancer.